JUPITER, Fla. (AP) — JUPITER, Fla. (AP) — Ligand Pharmaceuticals Inc. (LGND) on Thursday reported a loss of $42.5 million in its first quarter.
On a per-share basis, the Jupiter, …
Join our family of readers for as little as $5 per month and support local, unbiased journalism.
Already have an account? Log in to continue. Otherwise, follow the link below to join.
Please log in to continue |
JUPITER, Fla. (AP) — JUPITER, Fla. (AP) — Ligand Pharmaceuticals Inc. (LGND) on Thursday reported a loss of $42.5 million in its first quarter.
On a per-share basis, the Jupiter, Florida-based company said it had a loss of $2.21. Earnings, adjusted for non-recurring costs and stock option expense, were $1.33 per share.
The drugmaker posted revenue of $45.3 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $39.4 million.
Ligand expects full-year earnings in the range of $6 to $6.25 per share, with revenue in the range of $180 million to $200 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND
